Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Grant revenue $ 37,653 $ 131,521
Operating expenses:    
Research and development 15,490,604 10,072,684
General and administrative 5,451,952 4,479,605
Total operating expenses 20,942,556 14,552,289
Loss from operations (20,904,903) (14,420,768)
Other income (expense):    
Interest income 210,394 135,900
Interest expense (30,591) (15,103)
Miscellaneous income 69,363 11,582
Total other income, net 249,166 132,379
Loss before income taxes (20,655,737) (14,288,389)
Income tax benefit
Net loss $ (20,655,737) $ (14,288,389)
Basic net loss per share $ (9.18) $ (7.11)
Diluted net loss per share $ (9.18) $ (7.11)
Shares used to compute basic net loss per share 2,249,694 2,009,234
Shares used to compute diluted net loss per share 2,249,694 2,009,234